Tirzepatide, a recently approved medication, is sparking considerable excitement within the healthcare community. It functions differently from traditional diabetes medications, targeting both receptors involved in sugar regulation and appetite . Initial studies have demonstrated significant efficacy in lowering blood levels in individuals with typ